Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CRBP stock hub

Corbus Pharmaceuticals Holdings, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CRBPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

194.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CRBP

In the news

Latest news · CRBP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-54.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-36.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CRBP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001595097
Company name	Corbus Pharmaceuticals Holdings, Inc.
Country	United States
Country code	US
Cusip	21833P103
Employees	36
Employees Change	8%
Employees Change Percent	28.57
Enterprise value	$32.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US21833P3010
Last refreshed	2026-05-10
Market cap	$194.4M
Market cap category	Micro-Cap
Price	$10.96
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	CRBP
Website	https://www.corbuspharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-40.4%
FCF yield	-33.18%
P/B ratio	1.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-70.1M
Net Income	$-78.5M
Net Income Growth Years	0%
Profit Per Employee	$-2.2M
ROA	-32.91
Roa5y	-36.78
ROCE	-57.84
ROE	-54.18
Roe5y	-123.7
ROIC	-36.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-16.66%
Cagr1y	78.86%
Cagr3y	1.41%
Cagr5y	-26.04%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$168.2M
Cash	$163.3M
Current Assets	$167M
Current Liabilities	$20.7M
Debt	$1.6M
Debt Equity	$0.01
Equity	$147.5M
Liabilities	$20.7M
Long Term Assets	$1.2M
Long Term Liabilities	$0
Net Cash	$161.6M
Net Cash By Market Cap	$83.15
Net Cash Growth	10.84%
Net Debt Equity	$-1.1
Tangible Book Value	$147.5M
Tangible Book Value Per Share	$8.38
WACC	18.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.07
Net Working Capital	$-15.4M
Quick ratio	7.96
Working Capital	$146.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-22%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-83.83%
1Y total return	78.79%
200-day SMA	10.29
3Y total return	4.28%
50-day SMA	9.63
50-day SMA vs 200-day SMA	50under200
5Y total return	-77.86%
All Time High	323.4
All Time High Change	-96.61%
All Time High Date	2016-10-10
All Time Low	2.11
All Time Low Change	419.43%
All Time Low Date	2023-03-10
ATR	0.69
Beta	2.68
Beta1y	1.02
Beta2y	1.71
Ch YTD	34.64
High	11.28
High52	20.56
High52 Date	2025-10-20
High52ch	-46.69%
Low	10.79
Low52	6.25
Low52 Date	2025-05-08
Low52ch	75.36%
Ma50ch	13.79%
Price vs 200-day SMA	6.5%
RSI	64.67
RSI Monthly	45.36
RSI Weekly	56.49
Sharpe ratio	1.11x
Sortino ratio	1.8
Total Return	-22%
Tr YTD	34.64
Tr1m	12.87%
Tr1w	6.41%
Tr3m	39.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	1
Analyst Price Target Top	$40
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.23
Operating Income	$-85.3M
Price target	$45.5
Price Target Change	$315
Price Target Change Top	$265

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,741,478%
Float Percent	71.84%
Shares Insiders	0.55%
Shares Institutions	46.57%
Shares Out	17,736,464
Shares Qo Q	33.93%
Shares Yo Y	22%
Short Float	10.55%
Short Ratio	6.45
Short Shares	7.58

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-70.8M
Average Volume	312,233.3x
Bv Per Share	8.38
CAPEX	$-7,000
Ch10y	-83.83
Ch1m	12.87
Ch1w	6.41
Ch1y	78.79
Ch3m	39.97
Ch3y	4.28
Ch5y	-77.86
Ch6m	4.18
Change	0.83%
Change From Open	0.74
Close	10.87
Days Gap	0.09
Depreciation Amortization	233,000
Dollar Volume	2,641,151.8
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-85.3M
EBITDA	$-85.1M
EPS	$-5.9
F Score	1
FCF	$-64.5M
FCF EV Yield	-196.91x
FCF Per Share	$-3.64
Financing CF	77,426,000
Fiscal Year End	December
Founded	2,009
Investing CF	-1,641,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-09
Last Report Date	2025-12-31
Last Split Date	2023-02-14
Last Split Type	Reverse
Last10k Filing Date	2026-03-09
Ma150	10.36
Ma150ch	5.8%
Ma20	10.32
Ma20ch	6.18%
Net CF	11,294,000
Next Earnings Date	2026-05-22
Open	10.88
Optionable	Yes
Position In Range	34.69
Post Close	10.96
Postmarket Change Percent	-0.09
Postmarket Price	$10.95
Ppne	1,241,000
Price Date	2026-05-08
Ptbv Ratio	1.32
Relative Volume	0.77x
Share Based Comp	6,288,000
Tr6m	4.18%
Us State	Massachusetts
Volume	240,981

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CRBP pay a dividend?

Capital-return profile for this ticker.

Performance

CRBP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CRBP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+46.6%

Float: +71.8% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CRBP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

64.7

Neutral momentum band

Price vs 200-day MA

+6.5%

50/200-day relationship not available

Beta (5Y)

2.68

More volatile than the market

Sharpe ratio

1.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CRBP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CRBP stock rating?

Corbus Pharmaceuticals Holdings, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CRBP analysis?

The full report lives at /stocks/CRBP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CRBP?

The latest report frames CRBP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CRBP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.